loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 21810 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT (1)

filter

01 NOVO NORDISK INC (1)

filter

01 INJECTABLE;SUBCUTANEOUS (1)

filter

01 50 UNITS/ML;50 UNITS/ML (1)

filter

01 USA (1)

URL Supplier Web Content
INJECTABLE;SUBCUTANEOU...
50 UNITS/ML;50 UNITS/M...
NOVOLOG MIX 50/50
USA
21810
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21810

Looking for CTD TGA MCC DOSSIER APPLICATION 21810 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT, with a corresponding application number 21810 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLOG MIX 50/50 INJECTABLE;SUBCUTANEOUS, medication with 50 UNITS/ML;50 UNITS/ML of INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT.

Post Enquiry
POST ENQUIRY